TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.26M | -12.27M | -9.04M | -8.60M | -9.92M |
| Total Depreciation and Amortization | 266.00K | 264.00K | 225.00K | 248.00K | 270.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.19M | 2.05M | 2.80M | 2.07M | 1.38M |
| Change in Net Operating Assets | 426.00K | -1.21M | 1.15M | 564.00K | 367.00K |
| Cash from Operations | -9.38M | -11.17M | -4.87M | -5.72M | -7.91M |
| Capital Expenditure | -59.00K | -119.00K | -91.00K | -211.00K | -114.00K |
| Sale of Property, Plant, and Equipment | 298.00K | 309.00K | 283.00K | 523.00K | 318.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 239.00K | 190.00K | 192.00K | 312.00K | 204.00K |
| Total Debt Issued | -- | -- | 60.00M | -- | -- |
| Total Debt Repaid | -- | -- | -42.42M | -- | -- |
| Issuance of Common Stock | 0.00 | 28.00K | 11.82M | 45.00K | 0.00 |
| Repurchase of Common Stock | -15.00K | -79.00K | -4.00K | -21.00K | -3.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -247.00K | -3.55M | -- | -- |
| Cash from Financing | -15.00K | -298.00K | 25.85M | 24.00K | -3.00K |
| Foreign Exchange rate Adjustments | -10.00K | -26.00K | -35.00K | 104.00K | -152.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.17M | -11.30M | 21.13M | -5.28M | -7.86M |